ERO1α as a potential drug target for breast cancer: a systematic review of current evidence

Aim Recent studies reveal that hypoxia, oxidative stress, and impaired protein folding contribute to tumor development and breast cancer treatment resistance. Endoplasmic Reticulum Oxidoreductin 1 Alpha (ERO1α) regulates redox balance in the endoplasm

Authors

Mohamad Aljofan (ORCID: https://orcid.org/0000-0003-3205-3388)
Aiman Moldasheva
Kamilla Khojayeva

Institutions

Nazarbayev University (KZ)

Publication Details

Published: 2025-08-29
DOI: https://doi.org/10.22541/au.175648036.63225061/v1
Primary Topic: Mechanisms of cancer metastasis
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

ERO1α as a potential drug target for breast cancer: a systematic review of current evidence

Mohamad Aljofan, Aiman Moldasheva, Kamilla Khojayeva

Aug 29, 2025

1 links

Mechanisms of cancer metastasis

article

ERO1α as a potential drug target for breast cancer: a systematic review of current evidence

Mohamad Aljofan, Aiman Moldasheva, Kamilla Khojayeva

August 29, 2025article en

Abstract

Nazarbayev University (KZ)

Good health and well-being

Openalex Percentile: Top 80%

Mechanisms of cancer metastasis

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

ERO1α as a potential drug target for breast cancer: a systematic review of current evidence — Mohamad Aljofan, Aiman Moldasheva, et al. · (2025) | TGRS Research Map | TGRS